Longer term follow up of children experiencing chest pain following Pfizer mRNA vaccination finds persistent heart abnormalities
The Czars of epidemiology advise the government to continue mandates
A follow up study conducted at the Seattle Children's Hospital of children suffering myocarditis following their second dose of the Pfizer mRNA vaccine was published in the Journal of Pediatrics on 25 March 2022.
The study followed up 16 male children, with an average age of 15 years, 3 to 8 months after their initial diagnosis with myocarditis within a short time frame following mRNA vaccination.